Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ecstasy - drug

Known as: 5-Methoxy-3,4-methylenedioxyamphetamine, 3,4 methylenedioxymethamphetamine, 3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine 
A ring-substituted amphetamine derivative, structurally related to the hallucinogen mescaline, with entactogenic, neurotoxic, and motor-stimulatory… Expand
National Institutes of Health

Related topics

Related topics

18 relations
3,4-MethylenedioxyamphetamineClub DrugsIn BloodMethamphetamine
Expand

Broader (5)

Adrenergic Uptake InhibitorsAmphetamineDesigner DrugsHallucinogens
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
There is a longstanding association between substance-use disorders (SUDs) and the psychological construct of impulsivity. In the… Expand
  • table 1
  • table 1
  • table 2
  • table 3
Review
2007
Review
2007
Results from the 2008 National Survey on Drug Use and Health: National Findings
All material appearing in this report is in the public domain and may be reproduced or copied without permission from the… Expand
  • figure 2.1
  • figure 2.2
  • figure 2.6
  • figure 2.8
  • figure 2.10
Highly Cited
2005
Highly Cited
2005
Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds.
In this article, ultrafine gelatin (Gt) fibers were successfully produced with the use of the electrical spinning or… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table II
Review
2003
Review
2003
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
The amphetamine derivative (±)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a popular recreational drug among young… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Highly Cited
2003
Highly Cited
2003
Non-destructive terahertz imaging of illicit drugs using spectral fingerprints.
The absence of non-destructive inspection techniques for illicit drugs hidden in mail envelopes has resulted in such drugs being… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2002
Review
2002
Burnout and Self-Reported Patient Care in an Internal Medicine Residency Program
Context Burnout, a syndrome of emotional exhaustion, depersonalization, and perceived low personal accomplishment, is common… Expand
Review
2001
Review
2001
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
  • H. Kalant
  • CMAJ : Canadian Medical Association journal…
  • 2001
    • Corpus ID: 10844542
"Ecstasy" (MDMA) and related drugs are amphetamine derivatives that also have some of the pharmacological properties of mescaline… Expand
  • figure 1
Review
2000
Review
2000
Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004.
Johnston, Lloyd D.; O'Malley, Patrick M.; Bachman, Jerald G. The Monitoring the Future National Results on Adolescent Drug Use… Expand
Highly Cited
1998
Highly Cited
1998
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.
The sodium-dependent, high affinity serotonin [5-hydroxytryptamine (5-HT)] transporter (5-HTT) provides the primary mechanism for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1992
Highly Cited
1992
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
The risk of adverse reactions to 3,4-methylenedioxymethamphetamine (MDMA), more commonly known as "ecstasy", is now widely known… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE